Allergan, Inc. (NYSE: AGN)
| View: Annual | Quarterly | Dec 08 | Dec 07 | Dec 06 |
|---|---|---|---|
| Net Operating Cash Flow | 470.9 | 396.8 | 381.2 |
| Net Investing Cash Flow | (317.1) | (417.1) | (757.7) |
| Net Financing Cash Flow | (181.5) | (91.3) | 409.9 |
| Net Change in Cash | (32.8) | (105.9) | 37.3 |
| Depreciation & Amortization | 104.2 | 60.7 | 40.6 |
| Capital Expenditures | (131.4) | (71.0) | (67.1) |
| Cash Dividends Paid | (41.9) | (30.4) | (29.8) |
